[3as-?[2(s*)?,?3a,?4b,?6b,?7a]?]?-?Hexahydro-?3a,?5,?5-?trimethyl-?alpha-?(1-?methylethyl)?-?4,?6-?methano-?1,?3,?2-?benzodioxaborole-?2-?methanamine Trifluoroacetate is an impurity of Bortezomib (B675700), Bortezomib is the first proteasome inhibitor to be approved by the US FDA for multiple myeloma, a blood cancer. A reversible inhibitor of the 26S proteasome-a barrel-shaped multiprotein particle found in the nucleus and cytosol of all eukaryotic cells. Targets the ubiquitin-proteasome pathway.
